
CJ-13610
CAS No. 179420-17-8
CJ-13610( CJ13610 )
Catalog No. M12705 CAS No. 179420-17-8
CJ-13610 is a potent 5-Lipoxygenase (5-LO) inhibitor that suppresses 5-LO product formation with IC50 of 70 nM.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
5MG | 82 | Get Quote |
![]() ![]() |
10MG | 142 | Get Quote |
![]() ![]() |
25MG | 314 | Get Quote |
![]() ![]() |
50MG | 530 | Get Quote |
![]() ![]() |
100MG | Get Quote | Get Quote |
![]() ![]() |
200MG | Get Quote | Get Quote |
![]() ![]() |
500MG | Get Quote | Get Quote |
![]() ![]() |
1G | Get Quote | Get Quote |
![]() ![]() |
Biological Information
-
Product NameCJ-13610
-
NoteResearch use only, not for human use.
-
Brief DescriptionCJ-13610 is a potent 5-Lipoxygenase (5-LO) inhibitor that suppresses 5-LO product formation with IC50 of 70 nM.
-
DescriptionCJ-13610 is a potent 5-Lipoxygenase (5-LO) inhibitor that suppresses 5-LO product formation with IC50 of 70 nM; demonstrates antihyperalgesic activity in inflammatory pain models including the acute carrageenan model and the chronic inflammatory model.Asthma Phase 2 Discontinued.
-
In Vitro——
-
In Vivo——
-
SynonymsCJ13610
-
PathwayImmunology/Inflammation
-
TargetLipoxygenase
-
RecptorLipoxygenase
-
Research AreaInflammation/Immunology
-
IndicationAsthma
Chemical Information
-
CAS Number179420-17-8
-
Formula Weight393.505
-
Molecular FormulaC22H23N3O2S
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 10 mg/mL (25.41 mM)
-
SMILESO=C(C1(C2=CC=CC(SC3=CC=C(N4C=CN=C4C)C=C3)=C2)CCOCC1)N
-
Chemical Nametetrahydro-4-[3-[[4-(2-methyl-1H-imidazol-1-yl)phenyl]thio]phenyl]-2H-pyran-4-carboxamide
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Fischer L, et al. Br J Pharmacol. 2004 Jul;142(5):861-8.
2. Cortes-Burgos LA, et al. Eur J Pharmacol. 2009 Sep 1;617(1-3):59-67.
3. von Knethen A, et al. Cell Signal. 2013 Dec;25(12):2762-8.
molnova catalog



related products
-
KKII5
KKII5 is a potent inhibitor of the lipoxygenase LOX-1 with an IC50 of 19 μM.KKII5 inhibits lipid peroxidation and enhances the ability of the active centers of some compounds to receive electrons.
-
Tepoxalin
Tepoxalin is a 5-lipoxygenase inhibitor potentially for the treatment of asthma, osteoarthritis. Tepoxalin inhibits COX-1, COX-2, and 5-LOX.
-
ALOX15-IN-2
ALOX15-IN-2 is a potent inhibitor of ALOX15 linoleate oxygenase activity, inhibiting the oxidation of linoleic acid (LA) and arachidonic acid (AA), the immediate homologs of ALOX15, with IC50s of 1.55 and 2.79 μM, respectively.